2-hydroxyethylvaline has been researched along with fludrocortisone in 1 studies
| Studies (2-hydroxyethylvaline) | Trials (2-hydroxyethylvaline) | Recent Studies (post-2010) (2-hydroxyethylvaline) | Studies (fludrocortisone) | Trials (fludrocortisone) | Recent Studies (post-2010) (fludrocortisone) |
|---|---|---|---|---|---|
| 39 | 1 | 6 | 1,677 | 120 | 302 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckstein, A; Esser, J; Hoermann, R; Mann, K; Mueller, G; Quadbeck, B; Rettenmeier, AW; Steuhl, P | 1 |
1 other study(ies) available for 2-hydroxyethylvaline and fludrocortisone
| Article | Year |
|---|---|
Impact of smoking on the response to treatment of thyroid associated ophthalmopathy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Female; Fludrocortisone; Graves Disease; Hemoglobins; Humans; Male; Middle Aged; Ocular Motility Disorders; Prospective Studies; Smoking; Treatment Outcome; Valine | 2003 |